Synthesis and Evaluation of <i>N</i>-[1-(((3,4-Diphenylthiazol-2(3<i>H</i>)-ylidene)amino)methyl)cyclopentyl]acetamide Derivatives for the Treatment of Diseases Belonging to MAOs

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Compound</td><td class="align_center">IC50 (<i>µ</i>M)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left"><b>4a</b></td><td class="align_center">&gt;1000</td></tr><tr><td class="align_left"><b>4b</b></td><td class="align_center">&gt;1000</td></tr><tr><td class="align_left"><b>4c</b></td><td class="align_center">&gt;1000</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Cytotoxic activity of compounds <b>4a</b>, <b>4b</b>, and <b>4c</b> against NIH/3T3 cell line.</div>

Journal of Chemistry

tab2

Table 2

Table 2: Synthesis and Evaluation of <i>N</i>-[1-(((3,4-Diphenylthiazol-2(3<i>H</i>)-ylidene)amino)methyl)cyclopentyl]acetamide Derivatives for the Treatment of Diseases Belonging to MAOs 

Table 2 | Synthesis and Evaluation of N-[1-(((3,4-Diphenylthiazol-2(3H)-ylidene)amino)methyl)cyclopentyl]acetamide Derivatives for the Treatment of Diseases Belonging to MAOs 